Arsenic Prodrug-Mediated Tumor Microenvironment Modulation Platform for Synergetic Glioblastoma Therapy-Reference-Cited by-同舟云学术

Arsenic Prodrug-Mediated Tumor Microenvironment Modulation Platform for Synergetic Glioblastoma Therapy

Published:2022-08-03 Issue:32 Volume:14 Page:36487-36502
ISSN:1944-8244
Container-title:ACS Applied Materials & Interfaces
language:en
Short-container-title:ACS Appl. Mater. Interfaces

Author:

Yan Jiliang¹²,Hanif Sumaira¹²^ORCID,Zhang Dongya¹²,Ismail Muhammad¹²^ORCID,Wang Xiao¹²,Li Qianjin³^ORCID,Shi Bingyang¹²⁴,Muhammad Pir¹²^ORCID,Wu Haigang¹²

Affiliation:

1. Henan-Macquarie University Joint Centre for Biomedical Innovation, School of Life Sciences, Henan University, Kaifeng, Henan 475004, China

2. Henan Key Laboratory of Brain Targeted Bio-nanomedicine, School of Life Sciences and School of Pharmacy, Henan University, Kaifeng 475004, China

3. School of Food Science and Pharmaceutical Engineering, Nanjing Normal University, Nanjing 210023, China

4. Faculty of Medicine and Health Sciences, Macquarie University, Sydney, NSW 2109, Australia

Funder

Ministry of Science and Technology of the People's Republic of China

Judith Jane Mason and Harold Stannett Williams Memorial Foundation

National Health and Medical Research Council

Australian Government

National Foundation for Medical Research and Innovation

National Natural Science Foundation of China

Central Committee of the Communist Party of China

Publisher

American Chemical Society (ACS)

Subject

General Materials Science

Link

https://pubs.acs.org/doi/pdf/10.1021/acsami.2c12076

Reference69 articles.

1. Silver nanoparticles: synthesis, properties, and therapeutic applications

2. Degradable silver-based nanoplatform for synergistic cancer starving-like/metal ion therapy

3. Ultrahigh Sensitive and Tumor-Specific Photoacoustography in NIR-II Region: Optical Writing and Redox-Responsive Graphic Fixing by AgBr@PLGA Nanocrystals

4. Cancer therapeutic strategies based on metal ions

5. Reactive oxygen species (ROS) as pleiotropic physiological signalling agents

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. In-situ activated arsenic-molybdenum dual-prodrug nanocomplexes for glutathione-depletion enhanced photothermal/chemotherapy against triple-negative breast cancer;Chemical Engineering Journal;2024-10

2. An antioxidative-enhanced endoplasmic reticulum-targeted cyanine dye for efficient tumor immunotherapy;Chemical Engineering Journal;2024-08

3. Near Infrared-Activatable Biomimetic Nanoplatform for Tumor-Specific Drug Release, Penetration and Chemo-Photothermal Synergistic Therapy of Orthotopic Glioblastoma;International Journal of Nanomedicine;2024-07

4. Repression of YEATS2 induces cellular senescence in hepatocellular carcinoma and inhibits tumor growth;Cell Cycle;2024-02-16

5. Defect Engineering in Nanocatalysts: From Design and Synthesis to Applications;Advanced Functional Materials;2024-02-13